These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
324 related items for PubMed ID: 12860560
1. STAT signaling in ischemic heart: a role of STAT5A in ischemic preconditioning. Yamaura G, Turoczi T, Yamamoto F, Siddqui MA, Maulik N, Das DK. Am J Physiol Heart Circ Physiol; 2003 Aug; 285(2):H476-82. PubMed ID: 12860560 [Abstract] [Full Text] [Related]
2. Role of STAT3 in ischemic preconditioning. Hattori R, Maulik N, Otani H, Zhu L, Cordis G, Engelman RM, Siddiqui MA, Das DK. J Mol Cell Cardiol; 2001 Nov; 33(11):1929-36. PubMed ID: 11708838 [Abstract] [Full Text] [Related]
3. JAK/STAT signaling is associated with cardiac dysfunction during ischemia and reperfusion. Mascareno E, El-Shafei M, Maulik N, Sato M, Guo Y, Das DK, Siddiqui MA. Circulation; 2001 Jul 17; 104(3):325-9. PubMed ID: 11457752 [Abstract] [Full Text] [Related]
4. Remifentanil Preconditioning Reduces Postischemic Myocardial Infarction and Improves Left Ventricular Performance via Activation of the Janus Activated Kinase-2/Signal Transducers and Activators of Transcription-3 Signal Pathway and Subsequent Inhibition of Glycogen Synthase Kinase-3β in Rats. Qiao S, Mao X, Wang Y, Lei S, Liu Y, Wang T, Wong GT, Cheung CW, Xia Z, Irwin MG. Crit Care Med; 2016 Mar 17; 44(3):e131-45. PubMed ID: 26468894 [Abstract] [Full Text] [Related]
5. IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2. Dawn B, Xuan YT, Guo Y, Rezazadeh A, Stein AB, Hunt G, Wu WJ, Tan W, Bolli R. Cardiovasc Res; 2004 Oct 01; 64(1):61-71. PubMed ID: 15364614 [Abstract] [Full Text] [Related]
6. The functional role of the JAK-STAT pathway in post-infarction remodeling. El-Adawi H, Deng L, Tramontano A, Smith S, Mascareno E, Ganguly K, Castillo R, El-Sherif N. Cardiovasc Res; 2003 Jan 01; 57(1):129-38. PubMed ID: 12504822 [Abstract] [Full Text] [Related]
7. Activation of JAK/STAT pathway transduces cytoprotective signal in rat acute myocardial infarction. Negoro S, Kunisada K, Tone E, Funamoto M, Oh H, Kishimoto T, Yamauchi-Takihara K. Cardiovasc Res; 2000 Sep 01; 47(4):797-805. PubMed ID: 10974228 [Abstract] [Full Text] [Related]
8. PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase. Frasor J, Barkai U, Zhong L, Fazleabas AT, Gibori G. Mol Endocrinol; 2001 Nov 01; 15(11):1941-52. PubMed ID: 11682625 [Abstract] [Full Text] [Related]
9. Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways. Hu Y, Chen X, Pan TT, Neo KL, Lee SW, Khin ES, Moore PK, Bian JS. Pflugers Arch; 2008 Jan 01; 455(4):607-16. PubMed ID: 17674030 [Abstract] [Full Text] [Related]
10. Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Hausenloy DJ, Tsang A, Mocanu MM, Yellon DM. Am J Physiol Heart Circ Physiol; 2005 Feb 01; 288(2):H971-6. PubMed ID: 15358610 [Abstract] [Full Text] [Related]
11. An essential role of the JAK-STAT pathway in ischemic preconditioning. Xuan YT, Guo Y, Han H, Zhu Y, Bolli R. Proc Natl Acad Sci U S A; 2001 Jul 31; 98(16):9050-5. PubMed ID: 11481471 [Abstract] [Full Text] [Related]
12. Novel signal transduction pathway for luteinizing hormone and its interaction with insulin: activation of Janus kinase/signal transducer and activator of transcription and phosphoinositol 3-kinase/Akt pathways. Carvalho CR, Carvalheira JB, Lima MH, Zimmerman SF, Caperuto LC, Amanso A, Gasparetti AL, Meneghetti V, Zimmerman LF, Velloso LA, Saad MJ. Endocrinology; 2003 Feb 31; 144(2):638-47. PubMed ID: 12538627 [Abstract] [Full Text] [Related]
13. Regulating RISK: a role for JAK-STAT signaling in postconditioning? Goodman MD, Koch SE, Fuller-Bicer GA, Butler KL. Am J Physiol Heart Circ Physiol; 2008 Oct 31; 295(4):H1649-56. PubMed ID: 18708442 [Abstract] [Full Text] [Related]
14. Across-Species Transfer of Protection by Remote Ischemic Preconditioning With Species-Specific Myocardial Signal Transduction by Reperfusion Injury Salvage Kinase and Survival Activating Factor Enhancement Pathways. Skyschally A, Gent S, Amanakis G, Schulte C, Kleinbongard P, Heusch G. Circ Res; 2015 Jul 17; 117(3):279-88. PubMed ID: 26058828 [Abstract] [Full Text] [Related]
15. Coronary effluent from a preconditioned heart activates the JAK-STAT pathway and induces cardioprotection in a donor heart. Huffman LC, Koch SE, Butler KL. Am J Physiol Heart Circ Physiol; 2008 Jan 17; 294(1):H257-62. PubMed ID: 17982005 [Abstract] [Full Text] [Related]
16. ROS generated during early reperfusion contribute to intermittent hypobaric hypoxia-afforded cardioprotection against postischemia-induced Ca(2+) overload and contractile dysfunction via the JAK2/STAT3 pathway. Wu L, Tan JL, Wang ZH, Chen YX, Gao L, Liu JL, Shi YH, Endoh M, Yang HT. J Mol Cell Cardiol; 2015 Apr 17; 81():150-61. PubMed ID: 25731682 [Abstract] [Full Text] [Related]
17. Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning. Suleman N, Somers S, Smith R, Opie LH, Lecour SC. Cardiovasc Res; 2008 Jul 01; 79(1):127-33. PubMed ID: 18339648 [Abstract] [Full Text] [Related]
18. Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure. Booz GW, Day JN, Baker KM. J Mol Cell Cardiol; 2002 Nov 01; 34(11):1443-53. PubMed ID: 12431443 [Abstract] [Full Text] [Related]
19. Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway. Lacerda L, Somers S, Opie LH, Lecour S. Cardiovasc Res; 2009 Nov 01; 84(2):201-8. PubMed ID: 19666677 [Abstract] [Full Text] [Related]
20. Selective inhibition of PTEN preserves ischaemic post-conditioning cardioprotection in STZ-induced Type 1 diabetic rats: role of the PI3K/Akt and JAK2/STAT3 pathways. Xue R, Lei S, Xia ZY, Wu Y, Meng Q, Zhan L, Su W, Liu H, Xu J, Liu Z, Zhou B, Xia Z. Clin Sci (Lond); 2016 Mar 01; 130(5):377-92. PubMed ID: 26666444 [Abstract] [Full Text] [Related] Page: [Next] [New Search]